KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United…
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift…
URL: /atom11-wins-amazon-ads-partner-award-2025/ NASHVILLE, Tenn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- At atom11, we are proud to be building AI solutions…
Zhuhai, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ACASPRESSO, an emerging brand in the home appliance sector, has announced limited-time Black…
Nokia introduces MantaRay SON to NTT DOCOMO’s multi-vendor 5G network Nokia and NTT DOCOMO partner to revolutionize 5G Operations in…
York, Pennsylvania, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Pennsylvania Perio & Implants today announced the reinforcement of its evidence-based framework…
SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…
November 24, 2025 02:00 ET | Source: DXS International PLC Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of…
EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology…